{"name":"Armando Torres Ramírez","slug":"armando-torres-ram-rez","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"CsA with steroid minimization","genericName":"CsA with steroid minimization","slug":"csa-with-steroid-minimization","indication":"Other","status":"marketed"},{"name":"Tacrolimus with steroids minimization","genericName":"Tacrolimus with steroids minimization","slug":"tacrolimus-with-steroids-minimization","indication":"Other","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tacrolimus with rapid steroid withdrawal","genericName":"Tacrolimus with rapid steroid withdrawal","slug":"tacrolimus-with-rapid-steroid-withdrawal","indication":"Organ transplant rejection prevention (kidney, heart, liver transplants) with rapid corticosteroid withdrawal protocol","status":"marketed"}]}],"pipeline":[{"name":"Tacrolimus with rapid steroid withdrawal","genericName":"Tacrolimus with rapid steroid withdrawal","slug":"tacrolimus-with-rapid-steroid-withdrawal","phase":"marketed","mechanism":"Tacrolimus suppresses T-cell activation by inhibiting calcineurin, while rapid steroid withdrawal minimizes long-term corticosteroid exposure and associated toxicity in transplant recipients.","indications":["Organ transplant rejection prevention (kidney, heart, liver transplants) with rapid corticosteroid withdrawal protocol"],"catalyst":""},{"name":"CsA with steroid minimization","genericName":"CsA with steroid minimization","slug":"csa-with-steroid-minimization","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tacrolimus with steroids minimization","genericName":"Tacrolimus with steroids minimization","slug":"tacrolimus-with-steroids-minimization","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}